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Treatment of human ncutropllilr with the pcptidc f-MctLcu-Phc (FMLP) rcsul~ in ncutrophil acrivation concomitant with stimulation of 
phorphrfidylinoritol (PIdIns) 3-kioar activhy as measured by production of PIdIns-3,4.5-P, in [“Plorthophosphutc lab&d cells. Antiphospho- 
ryrosinc immunoprccipiintcs wcrc assayed l’or PidIns Skinaac activity: csscnrially no activity wns present in lyatcr from cithcr rtimulsrcd or 
unrtimulatcd cells. Tb: 85 kDa rqule~ory subunit of Ptdlnr 3mkinuss. which normally scrvcs as a rubsrrarc for tyrorinr kinnsss, was not dcrcctcd 
by SDS-PAGE or Western blot anlrlyris in antighorphotyrorinc immunoprcsipita:cr, In addition, no ndionctivc band corresponding IQ PIdIns 
3.kiness was obsccrvcd by SDS-PAGE followin untiPtdfnr 3.kinnrc immunoprccipitationr. Howcvcr, immunoprccipitatcs u ing polyclonal anti- 
bodiss apinst PtdInr 3.kinaet showed hiph Ptdlno 3.kinnsc rctivity in ncutrophil ysatcs ond the 85kDa subunit of Ptdlns 3-kinass was dctcctcd 
in Wcsrcrn bloir; no dilTcrcnccs in activity wcrc obscrrcd in FMLP-stlmulntcd and unstimulrtcd cells, Thclrc results ruggsst hat, in contmst to 
polypcpQde growth factor signal lransduclion systems. the nctivation of PIdIns 3.kinasc by FMLP doss not require tyrorinc phorphorylation. 
Ncutrophil uctivotion; Tyrosinc phorphoryliition; Phorphntidylinositol 3.kinarc; Signal transduction 
1. INTRODUCTION 
Chcmotactic agents such as the pcptidc N-formyl- 
Met-Lcu-Phc (FMLP) and lcukotricnc B4 activate RCU- 
trophils by atirnuking motility and causing changes in 
cycosktlctal strusturc and contractile apparatus [1,2j. 
Changes in accin polymerization induced by FMLP 
have been shown to bc concomitant with the formation 
of the novel phospholipid, phosphatidylinositol-3,4,5- 
trisphosphatc (PtdIns-3,4,5-P,) [3]. This lipid is one of 
three products of the cnzymc PtdIns %kinasc, a hctcro- 
dimcr of 110 kDa and 85 kDa subunits chat has been 
implicated in growth factor signal cransduscion by asso- 
ciating with a number of proteins containing intrinsic 
or associated tyrosinc kinasc activities, including the 
rcccptors for platelet-dcrivcd growth factor (PDGF) [4- 
6], insulin [7,8], and colony stimulating factor-1 [9,101, 
the products of oncogcncs v-src [l I], v-yes [l 11, and 
v-abf [121, as well as the polyomavirus middle T antigeti 
pp60c-src omplex [13], The 85 kDa subunit of PcdIns 
3-kinasc is phosphorylatcd by tyrosinc kinascs, inslud- 
ing the aforementioned rcccptors, in rcsponsc to growth 
Ccrrcrpondcncc uJdrcss: C, Ylehos, Cardlovasculer Rcssarch, Lilly 
Rcscarch Laboratories, Indianapolis, IN 46285-0403, USA. Fox: (1) 
(3 17) 276 9722. 
factor stimulation; it is thought hat phosphorylation of 
FtdIns 3-kinasc is critical for activation of the kinase 
and the subsequent micogcnesis seen in stimulated cells 
[14]. Since the FMLP receptor is not a member of the 
tyrosinc kinasc family of receptors and still activates 
Ptdlns 3-kinasc [15,16], it was of interest o determine 
if tyrosinc phosphorylation of Ptdlns 3-kinasc was rc- 
sponsiblc for stimulation of its activity. Results prc= 
scnccd bt:low suggest hat tyrosinc phosphorylation of 
Ptdlns 3-kinasc does nor occur following ncucrophil 
stimulation by FMLP, PcdIns 3.kinasc activity is not 
present in antiphosphotyrosinc immunoprecipitatcs, 
nor arc bands corresponding to the 85 kDa subunit of 
the kinasc present in SDS-PAGE analysis of chc an= 
tiphosphotyrosinc and antiPtdIns 3-kinasc immunoprc- 
cipitatcs. However, PcdIns 3-kinasc activity is stimu- 
lated by FMLP in neutrophils since the kinasc products 
arc detected following stimulation of cells by FMLP 
and sinsc the kinasc activity is observed in anti-PtdIns 
3.kinasc immunoprecipitatcs. Therefore it is apparent 
chat although Ptdlns 3-kinasc activity is stimulated in 
neutrophils following treatment with FMLP, tyrosinc 
phosporylation of PtdIns 3-kinase is not ncccssary for 
this activation. 
AbbrCVlurf0n.r: FMLF, ?/--ibrmyT+ict-lsu+hc; ‘Ftains, pimsphiiiii)i- 
linositol; PDGF, platclct-dcrivcd growth factor; PBS, phoaphatc-buff- 
crcd saline; HEPES, 4.(2.hyJroxycrhyl).l-pipcrazinccthancsulfonic 
acid; gFtdIne, glyccrophosphntidylinouitol. 
2. EXPERIMENTAL 
2.1. Mntcriais 
Anliphosphotyrosinc monoclonal antibodica nd anti.PtdIns 3.ki- 
nasc polyclonal antibodies wcrc obtained from Upsratc Biologicals, 
242 Publihd by I%cvicr Sdct~cr Pubhhrrs 6. V, 
Yolutnc 30% number 3 FEBS LE’ITERS ssgtclnbcr l!w 
Inc. Protein A-Srphnross, aprotinin. radium orthavanadatc, 
phorphotidylinoritol, bulylstcd hydronytGucnr (BHT), phcnylmcth- 
ylsulfonyl fluoride (PMSF), and diisopropyl fluorophoophatc (DFP) 
wcrc products of’ Sigma Chemical Company, Ins, [#‘]ATP (6ORfl 
Cimmol), [UP]orthophosphoric asld (HClJrcc, LLSOO-9120 Cihnnlal), 
Ptdlnr4phorph~tc (inositol IJH(N), IO Cilmmol), and PtdIns4,b 
biiphorphrlc (inoritol I=‘HRI), IO Ctimmol) wcrc products of New 
England Nuclear. FIow&int IV liquid scintillator we obteinsd l?om 
Radiomatis fnstrumcnts and Chsmiul Co.. Ins. Pralrincd SDS- 
PAGE molecular weight markcn (high and low rrn~~~# wcxc products 
of Bio-Rad Lnborntorics. Inc, Milli-Q water (Milliporc Carp,) was 
ussd for all rqucour rolurionr, All other rcrgsnto were of the highest 
quality commcrcblly available. 
2.2. ~cnrroplri! roloriwr 
Ncutrophilr wcrc isolated from freshly drawn, hcparin-trutcd 
human blood (25 ml) as follows, Blood wns carefully leycrcd onto I5 
ml Mono-Poly Resolving Medium (Flow Laboratories, Inc.), and the 
resulting suspsnrion centrifuged at 850 x p (30 min, 2O*C’). Plasma and 
monocytcs wcrc rcmovcd by upimtion, and the neutrophil4 arc 
carefully rcmovcd and rctuincd, Ncutrophilo wcrc twice washed in 
PBS (without Cn”), rcsuspndcd in 30 ml PBS, and quantitrtcd ruin& 
LI Cell-Dyn 1600 Counter. 
2.3. Phosphotiplpld /a&cling and cx;raction 
Ncutrophils wcrc l&&d with [UP]orthophorphntc p1 dcscribcd 
previously [l7], Ncutrophilr were wnshcd in 30 mM HEPES buffer, 
pH 7.4, containing 1 IO mM NISI. IO mM KCI, 1 mM M&la, and IO 
mM ~UCCISC (bulTcr A) containing 1.53 mM C&II. Cells wcrc rcsus= 
psndcd to a concentration of 5 x lO’/ml in calcium-free buffer A 
containinB2 m@ml BSA. [“PI-Grthophosghoricacid (0.5 mUmI) was 
sddcd and cells incubated III 37.C for 90 min. Cells mrc then washed 
thrcr times in calcium&cc buffer A, once in buffer A containing 1.53 
mM Ca”. and split into 1 ml rrrmplcs contnining 2 x IO’ cells. Cells 
wcrc prcincubatd at 37.C for 5 min and then wcrc cithcr trcatd with 
I fil DM?IU (unstimulatcd canrrol) or I ~1 DMSO containing FMLP 
(10 nM tinal conccntnrtion) for 60 s at 37*C, aRrr which time theccll 
ruspcnrion was transferred to a solution of 3 ml CHCIJMcGH (I:?. 
v/u)containing I mplml BHTnnd lOy&/ml PrdIndPtdIns4I’~tdlnr. 
4,5@, (I: I: I), CHCI, and 2,4 N HCI (2, I ml each) wcrc nddcd to the 
solution, which wns then ccntrifugcd, The lower CHCL, phase was 
removed while the upper phase WM wrrhcd 3 times with 1 ml CHCIL. 
The chloroform mshingr: wcrc combined and washed with 0.5 ml 
McOM/I N HCI (1: I, v/v), Following csntrifugation, thf lower CHCI, 
phase was rcmovcd, taken to dryncrr on a Buchlcr Vortex-Evapom- 
[or, and rcsuspsndcd in lOOy1 CHCI, for thin-layer chromatography 
on 20 K 20 cm Silica gel-60 plates (EM Scicncc) imprcgnatcd with 1.2% 
potassium oaalotc [17). Plates wcrc dsvclopsd inchloroform/acetone/ 
mcthnnollnsstic rcid/watcr (80:3O:ti24:14, v/v). Radiolabclcd 
phorpholipids wcrc dctcctcd by autoradiography, Migration of the 
products was compared to [“P]PtdIns-3-P. [“P]PIdIns-3,4-P,. and 
[J~D]Ptdlns-3,4,5~DJ formed by incubating [p”P]ATP and Pfdfnsl 
PtdIns4P/ Ptdlns4,5-Pl/phosphatidylscrinc (1:1:1:2,0.2 mg/ml) with 
purified bovine brain Prdhs 3akinarc; standard PtJIns, PtdIns4P, 
and PrdIi&,S.P, wcrc co-chromato@aphcd and visualizd by II 
vapor. 
Products of the Ptdfns kinasc reaction wcrc confirmed by HPLC 
[la]. Phospholipids wcrc dcasylatcd in mcthylaminc reagent and scpa- 
rated using a Whatman Perrisphcrc SAX anioncxchangc olumn as 
previously described [l9]. A Radiomalic Model A-100 Flo-Onc\Bcla 
on-line radioactivity detector was used to monitor the dcacylalcd 
[aaP]cnzymc products; [JH]gPtdIns4-P and [‘H]BPdIns4,5-P, wcrc 
added as internal standards. 
&4, ~&&y,pr~t&a labeling atut immutqrcclpiratlan 
loolstcd human ncutrophils wcrc labclod with [“P]orthophosphatc 
(I mCil§ x 10’ cells) as dcscribzd above except hat I.0 mM sodium 
orthovanndarc wns included in all buITcr& Aliquotr (0.5 ml) of lhr 
ncutrophil swpcnrion wcrc then trcatcd wi1h cithcr I ~1 DM50 (un- 
stimulated ti&rol) or I #I DM!3G cotuniting FMLP (IO nM final 
concentration) for 60 s. Stimulation wrriqucnchcd by addition of I ml 
inhibitor buffer (buffer A containin 1.53 mM C&la, IO0 mM NrF, 
10 mM EDTA, 2 mM IY-cthylmalsimidc, I mM (NHI],MoG,, 1 mM 
iodoacctic acid, I mM bcnzamidinc, and I mM sodium orthovena- 
date) [20], Cells wcrs then pllctcd in a microscntrirugc, rcaurpcndad 
in isctold inhibitor bulYcr containing 0.5 mM DFP [21], 20 PM 
Icupptin, and 10 yM pptatin, and incubated for IO min on ice. 
Ccllr wcm pcllctcd by micreccntrifu@tion, washed with 1 ml lyrir 
wash buff& (20 mM Tris-HCI @H 7.5), I37 mM N&I, 1 mM M&l,, 
1 mM C&II, and f mM radium orrhovenadatc) md were rhc& lyscd 
in I ml of 1% NP-40 lysis buffcrcontoining~ mM Trir-HCI (pH 7.5X 
137 mM N&I, 10% glycerol, 1 mM MgC&, I mM C&I,. 1 mM 
PMSF, I mM sodium ortbovnnadatc. 10 r@ml aprotinin, and IO 
)r@nl lcupptin at 4% for 20 min, Insolubls mat&l was removed 
by ccntril’u~ion at 10,000 K g for IO min at 4.C. Antiphosphoty- 
rorinc untibody (5 @g) or enti@tdIns 3-kinasc antiezra (5 yl) wcrc 
inwbetcd with the lysa~c ruprnrtants for 2 h at 4%. Immobilized 
protein A-Scpharosc bsads wfrc urcd to prcsipitrtc the antibcdy- 
antigen complcaa. Imsunoprccipitata wcrc mrhsd twise with I ml 
al’O.1 M Tris, 0.5 M LiCl (pH 7.5). Following the szsond wash 500 
~1 of the ruurpcndcd immunoprccipitatc wt16 ausycd for Ptdlns 3- 
kinnrc activity as dcrcribcd bslow, 5amglrr wcrc microccntrifugsd, 
and the resulting immunopcllrt from the rcmoining snmglc wns boiled 
for 5 min in loO~l4x SDS-PAGE sample buflcr (0.2 M Tri+HCl, pM 
6.8, containiny 40% glycerol, 4% SDS, 4% &mcrcaptocthanol, and 
0.025% Bromophcnyl blue). To ccl1 ly~trs not rubjclcd to im- 
munoprcfipitation wcrc lrddcd 250 plrlx SDS-PAGE sample bulTcr, 
samples wcrc boiled as nbovc. The [JzP]protclnr wcrc srpamtcd by 
SDS-PAGE on n 3.5% ~1. Gels wcrc subjcctcd toWcstcrn blot anal- 
yrir us dcscribcd blow or dried in vacua onto Whalman no. 3 pnpcr 
and analyzed by autoradiography. 
2.5, we$tcPI) blot 
The anti-PtdInr 3akinasc immunopcllctn wcrc warhsd twist with 0.2 
M Tris-HCI bull& pH 7.5. Eonmining 5 mM MnCI,. The im- 
munopcllcts wcrc then boiled for 5 min with 30 ~1 4x SDS-PAGE 
snmplc burcr. Proteins wcrc scprattcd by SDS-PAGE (7.5% 
scrylrmidc); Prdlnr 3skinar isolated frour Lovinc brain was used TV 
a poritivccontrol. Proteins wcrc tranrfcrrcd onto Hybond.ECL nitrce 
ccllulotc (Amcnhrm Corp.), and the mcmbnnc was then trcatcd with 
blocking buffer (5% non-fat dry milk in 20 mM Trls-HCI, pH 7.5, 
containing 500 mM NaCl and 0.05% Twccn 20). The mcmbranc was 
incubated overnight with the rabbit nnti.hdInr 39kinasc primary anti- 
body (I:500 dilution in blocking buffer containing 1% non-fat dry 
milk), and the blot was dcvclopcd using the Amcrshem enhanced 
chcmilumincsecncc detection method with donkey anti-rabbit I8G 
coupled to pcroxidasc as the sscondary antibody. 
2.6. Pilosphari~~l~loslrol J-kinasc arrivity 
The immunopcllcts wcrc assayed for Ptdlns 3.kinass aclivily as 
dcscribcd previously [13,221, The immunoprccipitatcs wcrc washcrl 
with 20 mM HEPES, pH 7.4, containing 10 mM MgCi: and 25 PM 
ATP, and were then resuspended in 40~1 of the above buffer contain- 
ing 32 PCi [y-“P]ATP. Rcastion was initiated upon addition of 10~1 
Ptdtnr sonicatcd in 20 mM HEPES buffer. pH 7,4 (0.2 mglml final 
conccniration), The samples wcrc incubated at room tcmpralurc for 
IO min with frcqucnt mixing, after which tima the rcaclion was 
qucnchcd by addition of 40 $1 1 N MCI. Lipids wcrc cxtractcrl with 
addition of 110 ~1 chlorofornUmcthanol (I :I, v/v). The samples wcrc 
ccntrifugcd and the lower organic phase was applisd to a silica gel 
TLC plate, which was dcvclopcd in CHClJMeOHlH~OMH,GH 
(45:35:8.5:1.5, v/v). Plates wcrc dried. and the kinasc reaction visual- 
ized by autoradiography. 
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Fig. I. Production of PIdIns-3,4.5-P, In FMtP.rtimulntcd nculro- 
phils. [‘V]Orthophorphatc l&&d ncurrophils wcrc slimulntcd wilh 
IO nM FMLP for 60 s, Phospholipids wcrc cxtracrcd nnd rcparatcd 
by thin-layer chrominogrnphy as dcrcribed in section 2. Mignticn of 
phorphtidylinositolr was compared to Ptdlnr-3-P. Prdlns-3&P,, and 
Ptdlns44,S~P, produced by purified bovine brain Ptdlnr J-kin=; 
standards of PIdIns, PtdIns-4 P. and P~dlns4,S.P: wcrc chromate. 
gmphcd and visurlizcd by I2 vnpor. 
3. RESULTS 
Il. Srimuhrion of Ptdhu 3-khuse activity in activated 
nrutrophiis 
Isolated human ncutrophils were incubated with 
[“P]orthophosphatc and then stimulated with FMLP 
(10 nM), Labeled phospholigids were extracted and an- 
alyzed by thin-layer chromatography (Fig. 1). Migta- 
tion of the products was compared to [“P]PtdIns-3-P, 
[‘xP]Ptdfns-3,4-P,, and [“P]PtdIns-3,4,5-P, produocd 
using purified bovine brain Ptdlns 30kinasc; standard 
PtdIns. PtdIns+P, and PtdIns+S-P2 were so-shroma- 
tographed and visualized by I2 vapor. Stimulation of 
ncutrophils with FMLP results in the rapid production 
of a novel [‘2P]phospllolipid migrating just below 
Ptdlns-P2 that is absent in the unstimulatcd ncutrophils. 
-This sompounri so-nigrarcd with PtdTins&i,W, pro- 
duced by bovine brain PtdIns 3-kinase. Previous invcsti- 
garors have identified this compound as PtdIns3,4,5-P, 
[IS, 171, and HPLC analysis following chemical dcacyla- 
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tion of the phosphatidylinositols sonfirrncd the identity 
of the novel phorpholipid (Fig. 21, PtdIns3,4,5-P, is not 
found in resting ncutrophils (Fig, 2A) but is formed 
within one minute foilowing stimulation by FMLP as 
cvidcnccd by the peak cluting at 66 min (Fig, 2B) co- 
mitjruting with cnzymatically synthesized Ptdtns3,cb.S 
P,(Fig. 2C). PtdIns3,4=P: was also producsd in ncutro- 
phils following FMLP stimulation. Production of 
PtdIns-3.4.5-P, and PtdIns-3,4-P2 suggests chc involvc- 
mcnt of PtdIns 3-kinasc in ncutroghil activation; thcrc- 
fore. experiments were pcrformcd to invcstigntc the role 
of this kinasc, 
Antibodies to phosphotyrosinc nnd Prdlns 3-kinasc 
were used in immunoprccipitorion experiments o rnsas- 
urc diffcrcncss in protein phosphorylntion bctwccn cslls 
stimulated with FMLP and unstimulntcd cells. Im- 
munoprccipittitcs from both FMLP~crcatcd and unstim- 
ulatcd cells were assayed for the prcscncc of Ptdfns 3- 
kinasc activity as well as for diffcrcnocs in phosphopro- 
tcin content among the two cell types, This wtlti acwm= 
plishcd by prclubcling cells with [“‘P]orthophosphatc 
prior to immunr;yrccipitation in the prwvcc of 1 .O mM 
sodium orthovanadatc o inhibit tyrosinc phosphntnscs, 
Fig. 3 depicts an autoradiograph comparing in vitro 
autophosphorylation with [lzlorthophosphatc prclabcl- 
ing of proteins isolated by antiphosphotyrosinc im- 
munoprccipitntion. Ccl1 iysates of unstimulatcd (lane 1) 
and FMLP-trcatcd (lane 2) ncutrophils show several 
phosphoprotcin bands ranging from 50-200 kDa; there 
appsars tc, bc no difference in phosphoprotcin sontcnt 
bstwccn the unstimulatcd and FMLP-trcatcd nsutro- 
phils. Antiphosphotyrosinc irnmunoprcsipitatcs of un- 
stimulated (lane 3) and FM1 P-treated (lane 4) ncutro- 
phi1 lysatcs also show scvcral prominent bands in the 
50-180 kDa range; however. no [“P]phosphoprotcin 
was observed at 85 kDn. corresponding to the rcguln= 
tory subunit of PtdIns 3-kinasc. A [“Plphosphoprotcin 
corresponding to PtdIns 3-killasc W&S also absent in 
antiPtdIns 3-kinasc immunoprcsipitates of unstimu- 
laced (lane 5) and FMLP-treated (lane 6) ncutrophil 
lysatcs, Thcsc findings suggest hat PtdIns 3-kinasc is 
not phosphorylatcd in rcsponsc to ncutrophil stimula- 
tion by FMLP, 
3.3. Plrospf~ucirlylirtosirol 3-k&me uctivicy 
Antiphosphotyrosinc immunoprccipitatcs wcrc as- 
sayed for the presence of PtdIns 3-kinasc activity. As 
indicated in Fig. 4n, no cnzymatis activity was prcscnt 
in both unstimulatcd and FMLP-treated sells, suggcst- 
ing that tyrosine phosphorylation of PtdIns 3=kinasc did 
not occur in fortiyl pcptidc.trcatcd ncutrophils. In con- 
trast to nntiphosphotyrosinc immunoprccipiinfcs, rieu- 
trophil lyaate immunoprccipitatcs u ing polyslonal an- 
tisera against the 85 kDa subunit of PtdIns 3-kinase 
show very high PtdIns kinase activity in both stimulated 
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Fig, 2. HPLCarmlysis afdcncylatcd Pfdlnrqhosphntcs. P~dfns~phor~ 
phatu WC cntmc~cd from TLC plrtcs. chcmisally dcxylntcd will1 
mcthylaminc, and ruhjcctcd to anion exchange HPLC anPyris using 
an an-line radiochcmial detector as dcrcribcd in salian 2. A. un- 
slintulatcd ncutrophils: D, FMLP~rrcatcd ncutro hils; C, pradurls of 
purified bovine bruin PtdInr &kinasc; D, f [ H]gPtdIns+P arId 
[LH]gPtdlns.4,S-P, internal srimderdr. 
and control cells (Fig. 4b); I-IPLC analysis of the dcacyl- 
aced lipid products of the PtdIns kinasc assay confirms 
that the Ptdlna kinasc activity in these cells is due CO the 
PtdIns 3-kinass rather than due to PtdIns 4-kinasc (Fig. 
4~). This indicates that ncutrophils contain very sign& 
cant Ptdlns 3-kinasc activity, but that tyrosinc phos- 
phorylation of PtdIns 3-kinasc does not occur as indi- 
cated by the absence of the kinasc in antiphosphoty- 
rosinc immunoprccipitatcs (Fig. 4a). 
Western blot analysis using the polyclonal antisera 
against he 8H2 domain of the 85 kDa regulatory sub- 
unit of PtdIns 3=kinase was pcrformcd on the im- 
munoprccipicatcs obtained from using both the an- 
tiphosphotyrosinc and anti=PtdIns 3.kinasc antibodies 
(Fig. 5). The PtdIns 3-kinasc is not found in an- 
tiphosphotyrosinc immunoprccipitatcs, asindicated by 
the obscnce of the 85 kDa band in both the stimulated 
and unstimulatcd lysatcs (lanes 1 and 2). Mowever, the 
85 kDa subunit is present in the anti-PcdIns 3-kinasc 
immunoprecipitatc samples; no apparent differences are 
seen bctwccn stimulated and control samples (lanes 3 
and 4). Scvcral Wcstcrn-positive bands are seen, cspc- 
ddty Zio;tti8Sk&Xd 5t!k~,%+icf:~tst~~COZE~ 
ponents of the rabbit antibody (lane T), but only the 85 
kDa hand in the anti-PtdIns 3-kinasc imnunoprccipi- 
tatcs correlates to PtdIns 3-kinass isolated from bovine 
Fip. 3. [“P]Dhosphoprotoin anrlyris from ncutrophil lylratss, Mcutro- 
philr wcrc labclecl with [“P~onhophorphalc us dcccribcd in s&lion 2. 
Luncs 1 und 2. ccl1 lyrutc of unslimululcd and FMtPmwd ncurro. 
phils. resp%livcly; Inncs 3 ilnd 4, nnriphosphotyrosinc immunoprcclp 
ir;r\ex of ccl1 lyrntca from unstimulatcd and FMLP-\ratcd ncutrophil 
lysa~cz. respectively: lanes 5 und6, antiPtdIns3-kin= immunoprccip 
itrtcs of ccl1 lysatcr from unstimultitcd lrnd FMLP-~rcarcd nrulrophil 
lysa~cs. rcspcclivcly, SDS-PAGE was pcrf~~~~cd on 7.5% rlcrylnmidc 
yclr ols described in salion 2. Molecular wright mrrkcrr: 205 kDa, 
myorin: 1165 kDs. &alactosidurc; 10 kDa. bovine srum albumin; 
49.5 kDa, ovalbumln. 
brain. which was used as a positive control for tht 85 
kDa subunit (lane 6). The anti-PtdIns J-kinase antisera 
was raised against he .%I2 domain of the 85 kDa rcgu- 
latory subunit; therefore, the 110 kDa wuhunic is not 
prcssnt in the Western blots since it is not rccogni;zsd 
by the nnti-Ptdlns 3-kinasc antisera. A faint band mi- 
gracing to around 40 kDa in chc anti=PtdIns ?-kinesc 
immunoprecipitatcs is not present in the bovine brain 
PtdIns 3-kinasc ontrol lane, nor is it found in the an- 
tiphosphotyrosine immunoprecipitatss. The identity of 
this protein is not known; it may represent another 
SHZ-containing protein that was rccognizcd by the pol- 
yclonal antisera, or may be due to ccllulur protcolytic 
processing of the 85 kDa subunit of the kinasc, Mow- 
ever. the abscncc of PtdIns 3-kinasc in ths an- 
tiphosphotyrosinc immunoprccipitatcs further substan- 
tiates that although ths Ptdtns 3.kinasc is prcscnt in the 
ncutrophil. tyrosinc phosphorylation of ths kinasc does 
not occur. 
4. DISCUSSION 
PtdIns 3.kinasc is an cnaymc that associates with a 
r.umber of pro*Gxs that bass imrinsio of associated 
tyrosinc kinase activities including the receptors for 
PDGF [4,5,6], insulin [7,81, and colony-stimulating fac- 
tor-l [9,10], the products of oncogcnes Y-src [I 11. V-JV~ 
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Fia. 4. Autoradiograph of Ptdlns 3&inasc assay. A, anliphorphotyrosinc immunoprccipitarcs; 8, antidtdInr-Skinarc immunoprecipitatcr, Im- 
munopsllcts wcrc assayed with PtdIns and [“P]ATP PI dcssrihd in scclion 2. C, identity of the ndioactivc enzymatic product as Pldlnr-3-P was 
confirmed by HPLC analysis following chemical dcacylaiion (upper panel) by comparison to an intcrnul standard of [‘H]gPtdInr4P (lower panel). 
[l 11, and wbl [la], as well (LS the polyomavirus middle 
T antigcn/ppSOc-src complex [13]. The enzyme is a 
hctcrodimcr of 110 kDa and 85 kDa subunits [23]: the 
85 kDn subunit binds to tytosinc kinases and serve as 
one of its substrates 124-261. Mutunts of the PDGF- 
receptor that lack the PtdIns 3-kinosc bindin site fail 
to have associated PtdIns 3-kinass activity, and cells 
expressing these mutant rcscptors foil to show increased 
DNA synthesis and cell division, suggesting an impor- 
tant role for PtdIns 3-kinasc in mitogcncsis [27,28]. To 
dote, however, the physiological role of PtdIns 3-kinnst 
or its products has not been elucidated, although there 
is some suggestion about the role of the PtdIns-3-phos- 
phucs involved in the regulation of cytoskclctal struc- 
ture [3,29]. 
Tyrosinc phosphorylation of Prdins 3-kinase is 
thought to bc essential for its activation in polypeptidc 
growth factor-receptor systems [141, perhaps involving 
translocation of the PtdIns 3-kinasc to the ccl1 mcm- 
branc [30]. Although the FMLP rcscptor dots not have 
intrinsic tyrosine kinasc activity, it ia possible thnt a 
coupled cytosolis tyrosine kinnsc could be involved in 
Ptdlns 3-kinasc activation It has previously been dcm- 
onstratcd that tyrasinc phosphorylntion occurs in octi- 
vatcd human neutrophils [31-331, but none of these 
studies have linked tyrosine phosphorylntion with 
PtdIns 3-kinasc activation. Experiments were therefore 
pcrformcd to examine whether Ptdlns 3-kinasc is 
phosphorylatcd on tyrosinc following stimulation with Be-- L PM l-i-, 
In contrast to cxpsrimcnts performed in fibroblasts 
or smooth muscle cells [ 18,193, antihodics raised agtiinst 
phosphotyrosinc do not immunoprccipitotc PtdIns 3- 
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kinass activity in ncutrophils, suggesting that the cn- 
aymc is not phosphorylatcd on tyrosinc in activated 
ncutraphils. Ptdlns 3-kinasc activity was absent in an- 
tiphosphotyrosine immunoprccipitatcs from both un- 
stimulated and FMLP-treated ncutrophils (Fig. 4a), 
and the 85 kDo protein representing the regulatory sub- 
uniL of Ptdlns 3-kinssc was not present in ccl1 lysatcs or 
antiphosphotyrosinc immunoprccipitatcs using SDS- 
PAGE analysis of the “P-l&&d proteins (Fig. 3), or 
anti-PtdIns 3-kinasc Western blots from nntiphosphoty- 
rosinc immunoprecipitations (Fig 5). Howcwcr, it is 
evident hat PtdIns 3-kinasc is present in the ncutrophil, 
as dcmonstrotcd by the production of PtdIns-3,4,5-P, 
upon stimulation with FMLP (Figs, 1 and 2), the ability 
to measure Ptdfns 3-kinasc activity in anti-Ptdfns 3- 
kinasc immunoprccipitata (Fig, 4), and the presence of 
the 85 kDa subunit in Western blots following anti- 
PtdIns 3-kinesc immunoprccipitations (Fig. 5). While it 
is certainly possible that tyrosine phosphorylntion oc- 
curs on a small fraction of PtdIns 3-kina* in ncutro- 
phils, similar experiments performed in 3T3 flbroblasts 
support the findings presented in this report, Stimula- 
tion of 3T3 cells with PDGF results in the presence of 
PtdIns 3-kinasc in antiphosphotyrosinc immunoprccip- 
it&ions; this activity is absent in unstimulatcd cells. The 
amount of PtdIns 3-kinass activity in antiphosphoty- 
rosinc immunoprccipitations appears to constitute less 
than 1% of the total PtdIns 3-kinasc activity when com- 
pared to anti-PtdIns 3-kinase immunoprccipitations 
1&V.,. d. d M. l .>.erm. c-e Yl-2+ lQJU@M Tlxzs, &llugh anly il %x-&all fiat- 
tion of PtdIns 3-kinasc activity in 3T3 cells is present i  
antiphosphotyrosinc immunoprccipitatss, it is clearly 
and significantly present compared to unstimulated 
Vol FEDS ssplcnlxr 1992 umc 30% number 3 
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Fig. 5. Western blot of Ptdfnr3Gnarcin immunopcllcts, tancs I end 
1. unmimuhfcd Pnd FMLlQrc;l~cd lyr;ltc 00~1 ;rntipfla~pitotyrcsinc 
imnrunopmcipit;llc: hmcr 3 und 4, unstimulatccl und FMtfQrcatcd 
lyrutc from anti-Ptdlnr 3mkimtilxc immunoprccipit;rtcs: I;mc S. rubbit 
nn&Pldlnr 3.kinasc antibody: lvnc 6. Ptdlns 3-kinusc is&tcd liom 
bovine braln. 
control. This is in contrast to the fludings prcscntcd in 
this report ior the ncutrophil. Antiphosphotyrosinc im= 
munoprecipitatcs show no stimulnticn of PtdIns 3-ki- 
nasc activity in FMLP stimulated ncutrophils. E:;scr,- 
titrlly no PtdIns 3-kinasc uctivity is prcscnt in both un- 
stimuiatcd and FMLP-treated ncutrophils. These data. 
as well as the absence of Ptdlns 3-khnsc in Western 
blots of antiphosphotyrosinc immunoprccipitatcs and 
the absence of the kinasc in antiphosphotyrosinc im- 
munoprccipitlrtes from LaP-labcfcd ccl1 lysntcs, strongly 
suggest hat tyrosinc phosphorylation of PtdIns 3-ki- 
nasc does not occur during ncutrophil activation. 
On the surface. it would appear that the presence of 
PtdIns 3-kinasc in ncutrophils and its activation fol- 
lowing FMLP stimulution would bc contrary to prcvi- 
ous reports suggesting a direct link bstwccn PtdIns 3- 
kinusc activity and mitopncsis [27,28] since ncutrophils 
arc nonprolifcruting cells and the chcmotactic pptidc 
rcccpcor is not a tyrosinc kinasc. Mowcvcr. the produc- 
tion of PtdIns-3,4,5-P, is concomitant with change in 
actin polymerization in ncutrophils stimulated with 
FtiLP 3’ f xx! &xqJcs ir; iic%n *~r”~n~rki, ?5rruourc a. ,b,L,L ! l r.“.*..u 
also occu? during mitogcncsis [34-361. Furthcrmorc, 
these cytoskelct;ll changes arc mediated in part by 
PtdIns-4,5-P,, which has been demonstrated to bind to 
proluctin, gclsolin, and villin end therefore promote 
sctin polymcrizPtion [37-393. A possible role for Ptdlns- 
3.45PJ production may be to induce astin polymsriza- 
(ion in rcsponac to mitogcnie or chcmotactic stimuli. 
In summary. PtdIns 3-kinasc activity is stimulated ip 
nculroghils tmtcd with FMLP. but tyrasins phospho- 
rylation of Ptdlns 3-kinosc dots not occur. The presence 
of PtdIns 3-kinnsc activity has been dcmonstratcd by 
measuring activity in anti-Ptdtns 3-kinasc irnmunoprc- 
cipitrrtcs as well as the isolation of its product PtdIns- 
3.4.5-P, from stimulated ncutrophils. Mowcucr, the as- 
tivity is not present in antiphosphotyrosinc immunopre 
cipitatcs. again supporting that tyrosinc phosphorylac 
tion is not nsccssay for the stimulation OF PtdIns 3- 
kinasc activity. These results suggest hat in nonrnito= 
gcnic cells. an alternate mechanism for Ptdlns 3-kinasc 
activation is present hat does not rcquirc tyrosinc phos- 
phorylation but still enables responses uch as actin 
polymerization to occur. 
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